High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth

BACKGROUND: Although cholesterol metabolism is a common pathway for the development of antitumor drugs, there are no specific targets and drugs for clinical use. Here, based on our previous study of sterol O-acyltransferase 1 (SOAT1) in hepatocelluar carcinoma, we sought to screen an effective targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihua, Wang, Miaomiao, Zhang, Mengxin, Xu, Kaikun, Zhang, Xinshuai, Xie, Yi, Zhang, Yiming, Chang, Cheng, Li, Xiaolu, Sun, Aihua, He, Fuchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361549/
https://www.ncbi.nlm.nih.gov/pubmed/35941608
http://dx.doi.org/10.1186/s12916-022-02436-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361549/
https://www.ncbi.nlm.nih.gov/pubmed/35941608
http://dx.doi.org/10.1186/s12916-022-02436-8

Ejemplares similares